Evogene Ltd (NASDAQ: EVGN) Stock Information | RedChip

Evogene Ltd (NASDAQ: EVGN) Listen to this Section


$4.06
-0.1000 ( -2.40% ) 4.7K

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

Market Data


Open


$4.06

Previous close


$4.16

Volume


4.7K

Market cap


$21.08M

Day range


$4.07 - $4.17

52 week range


$3.79 - $10.40

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 5 Apr 02, 2024
20-f Annual reports 122 Mar 28, 2024
6-k Quarterly Reports 4 Mar 28, 2024
6-k Quarterly Reports 3 Mar 20, 2024
6-k Quarterly Reports 3 Mar 07, 2024
6-k Quarterly Reports 4 Feb 22, 2024
6-k Quarterly Reports 4 Feb 21, 2024
6-k Quarterly Reports 3 Jan 17, 2024
6-k Quarterly Reports 46 Jan 09, 2024
6-k Quarterly Reports 4 Dec 19, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.